Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

HAE
Haemonetics Corporation
stock NYSE

At Close
Feb 27, 2026 3:59:52 PM EST
63.34USD+1.767%(+1.10)620,628
0.00Bid   0.00Ask   0.00Spread
Pre-market
Feb 24, 2026 8:12:30 AM EST
62.51USD+0.434%(+0.27)0
After-hours
Feb 27, 2026 4:15:30 PM EST
63.32USD-0.032%(-0.02)881
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
2.94B
CEO
Christopher Simon
Headquarters
Boston, Massachusetts, USA
Industry
Medical Instruments & Supplies
Next Earnings
May 7, 2026 (67d)
Last Split
Dec 3, 20122for1
Related
CERSBAXBDXJNJSYKTMOPKIMDTXLV
HAE Stats
Avg. Vol. 10 Day
771,804
Avg. Vol. 30 Day
1,001,931
Employees
3,136
Market Cap
2,943,030,596
Shares Out.
46,471,350
On/Off Exchange
55%/45%
6 Month Beta
-0.11
1 Year Beta
0.60
2 Year Beta
0.59
3 Year Beta
0.65
52 Week Low
47.32
52 Week High
87.32
SMA50
70.77
SMA200
66.15
1 Week
+3.50%
1 Month
-4.13%
3 Month
-22.15%
6 Month
+16.54%
1 Year
-3.31%
2 Year
-15.41%
5 Year
-51.06%
Profile
haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn't need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right

HAE Stock Summary

Haemonetics Corporation (NYSE:HAE) stock price today is $63.34, and today's volume is 620,628. HAE is up 1.767% today. The 30 day average volume is 1,001,931. HAE market cap is 2.94B with 46,471,350 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC